Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy.
Clin Exp Rheumatol. 2022 Sep;40(9):1611-1619. doi: 10.55563/clinexprheumatol/x3sfxe. Epub 2022 Sep 19.
Psoriatic arthritis is a systemic autoimmune disease, in which a characteristic heterogeneous inflammatory involvement of entheses and both peripheral and axial joints tends to be associated with different clinical features, in particular skin or nail psoriasis, but also inflammatory bowel diseases, or acute anterior uveitis. Patients with PsA are at higher risk of developing comorbidities, in particular metabolic syndrome, with a significant impact on their quality of life. Although the advanced knowledge in the pathogenetic mechanisms of PsA helped in developing an abundant therapeutical armamentarium, the available drugs might still show a suboptimal efficacy. However, the frontier of "personalised medicine" could promote further future improvement in the quality of care of patients. In this paper we reviewed the literature on PsA of 2020 and 2021 (Medline search of articles published from 1st January 2020 to 31th December 2021).
银屑病关节炎是一种系统性自身免疫性疾病,其特征为肌腱附着点和外周及中轴关节的异质性炎症浸润,往往与不同的临床特征相关,特别是皮肤或指甲银屑病,但也与炎症性肠病或急性前葡萄膜炎相关。银屑病关节炎患者发生合并症的风险更高,特别是代谢综合征,这对其生活质量有重大影响。尽管银屑病关节炎发病机制的深入了解有助于开发丰富的治疗手段,但现有药物的疗效仍可能不理想。然而,“个性化医疗”的前沿技术可能会促进患者护理质量的进一步提高。本文回顾了 2020 年和 2021 年的银屑病关节炎文献(对 2020 年 1 月 1 日至 2021 年 12 月 31 日期间发表的文章进行 Medline 检索)。